United Therapeutics Corporation (NASDAQ:UTHR) Q2 2025 Earnings Call Transcript July 30, 2025
United Therapeutics Corporation misses on earnings expectations. Reported EPS is $6.41 EPS, expectations were $6.8.
Operator: Good morning, and welcome to the United Therapeutics Corporation Second Quarter 2025 Corporate Update. My name is Steve, and I’ll be your conference operator today. [Operator Instructions] Please note, this call is being recorded. I will now like to turn the webcast over to...
